Feng Sun

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Diabetes, obesity & metabolism

Clinical pharmacology and therapeutics

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Evidence-based complementary and alternative medicine : eCAM

Peking University Health Science Center

Peking University Health Science Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking University Health Science Center Dec 21 2012

China

Associate Professor :: Epidemiology and Bio-statistics, School of Public Health

Harvard Pilgrim Health Care Institute Dec 31 2016 - Jan 06 2018

United States

Visiting Associate Professor :: Department of Population Medicine

Education History

Peking University Health Science Center Aug 26 2006 - Jul 15 2009

China

PHD :: Department of Epidemiology and Bio-statistics

Publications

Zhi-Rong Yang, Hua He, Rui Wang, Dongyang Liu, Ge Li, Feng Sun
Application and Quality of Model-Based Meta-Analysis in Pharmaceutical Research: A Systematic Cross-Sectional Analysis and Practical Considerations. Clinical pharmacology and therapeutics (2024)
Sanbao Chai, Yapin Niu, Fengqi Liu, Shan-Shan Wu, Zhi-Rong Yang, Feng Sun
Comparison of GLP-1 Receptor Agonists, SGLT-2 Inhibitors, and DPP-4 Inhibitors as an Add-On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review. Journal of diabetes research 2024 (2024)
Zhi-Rong Yang, Hua He, Rui Wang, Dongyang Liu, Ge Li, Feng Sun
Application and Quality of Model-Based Meta-Analysis in Pharmaceutical Research: A Systematic Cross-Sectional Analysis and Practical Considerations. Clinical pharmacology and therapeutics 116 (2) (2024)
Sanbao Chai, Yapin Niu, Fengqi Liu, Shan-Shan Wu, Zhi-Rong Yang, Feng Sun
Comparison of GLP-1 Receptor Agonists, SGLT-2 Inhibitors, and DPP-4 Inhibitors as an Add-On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review. Journal of diabetes research 2024 (2024)
Zhi-Rong Yang, Hua He, Rui Wang, Dongyang Liu, Ge Li, Feng Sun
Application and Quality of Model-Based Meta-Analysis in Pharmaceutical Research: A Systematic Cross-Sectional Analysis and Practical Considerations. Clinical pharmacology and therapeutics 116 (2) (2024)
Qin Yang, Baoqi Zeng, Jiayi Hao, Qingqing Yang, Feng Sun
Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis. Diabetes, obesity & metabolism 26 (9) (2024)
Qin Yang, Baoqi Zeng, Jiayi Hao, Qingqing Yang, Feng Sun
Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis. Diabetes, obesity & metabolism (2024)
Hongmei Zeng, Maomao Cao, Changfa Xia, Dongmei Wang, Kun Chen, Zheng Zhu, Ruiying Fu, Shaokai Zhang, Jinyi Zhou, Huadong Wang, Xianyun Qi, Shuguang Dai, Yong Chen, Zhong Sun, Hao Ding, Qingwen Li, Hui Zhao, Xuehong Zhang, Jakub Morze, John S Ji, Feng Sun, Xue Qin Yu, Chunfeng Qu, Wan-Qing Chen
Publisher Correction: Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study. Nature cancer (2023)
Hongmei Zeng, Maomao Cao, Changfa Xia, Dongmei Wang, Kun Chen, Zheng Zhu, Ruiying Fu, Shaokai Zhang, Jinyi Zhou, Huadong Wang, Xianyun Qi, Shuguang Dai, Yong Chen, Zhong Sun, Hao Ding, Qingwen Li, Hui Zhao, Xuehong Zhang, Jakub Morze, John S Ji, Feng Sun, Xue Qin Yu, Wan-Qing Chen, Chunfeng Qu
Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study. Nature cancer (2023)
Yun Lu, Meng Zhang, Qing-Qing Yang, Wen-Jing Li, Kun Yang, Wen Hu, Su-Yu Gao, Qiao-Li Jiang, Li-Kai Lin, Hong Cheng, Feng Sun
Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Yun Lu, Meng Zhang, Qing-Qing Yang, Wen-Jing Li, Kun Yang, Wen Hu, Su-Yu Gao, Qiao-Li Jiang, Li-Kai Lin, Hong Cheng, Feng Sun
Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Zhike Liu, Pei Li, Xueyang Zeng, Xiaoying Yao, Yexiang Sun, Hongbo Lin, Peng Shen, Feng Sun, Siyan Zhan
Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort. BMC public health 22 (1) (2022)
Qi Zhou, Dan Xing, Qinyuan Li, Jingyi Zhang, Xufei Luo, Nan Yang, Xiaoqin Wang, Ke-Hu Yang, Jinhui Tian, Hui Li, Bo Li, Yujia Cai, Yinghui Jin, Lanting Lv, Feng Sun, Shuxian Shang, Beibei Yuan, Jiang Li, Bin Ma, Xiuxia Li, Yuanzhi Yuan, Lei Wu, Bin Wang, Lei Jiang, Zhiwen Wang, Yaolong Chen, Du Liang
An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT. Journal of evidence-based medicine 15 (1) (2022)
Baoqi Zeng, Hao Jia, Le Gao, Qingqing Yang, Kai Yu, Feng Sun
Dual-hormone artificial pancreas for glucose control in type 1 diabetes: A meta-analysis. Diabetes, obesity & metabolism 24 (10) (2022)
Haibo Song, Xiaojing Pei, Zuoxiang Liu, Chuanyong Shen, Jun Sun, Yuqin Liu, Lingyun Zhou, Feng Sun, Xiaohe Xiao
Pharmacovigilance in China: Evolution and future challenges. British journal of clinical pharmacology (2022)
Shengzhi Sun, Qingqing Yang, Qingxin Zhou, Wangnan Cao, Siwang Yu, Siyan Zhan, Feng Sun
Long-term exposure to fine particulate matter and non-alcoholic fatty liver disease: a prospective cohort study. Gut (2021)
Zhigang Zhao, Jiashu Shen, Chuanyong Shen, Bin Zhu, Jun Sun, Jinyang Yu, Feng Sun, Haibo Song
An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China. Current medical research and opinion 37 (11) (2021)
Jichun Yang, Shuqing Yu, Zhirong Yang, Yusong Yan, Yao Chen, Hongmei Zeng, Fei Ma, Yanxia Shi, Yehui Shi, Zilu Zhang, Feng Sun
Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta-Analysis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (4) (2019)
Shanshan Wu, Le Gao, Andrea Cipriani, Yi Huang, Zhirong Yang, Jun Yang, Shuqing Yu, Yuan Zhang, Sanbao Chai, Zilu Zhang, Feng Sun, Siyan Zhan
The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials. Diabetes, obesity & metabolism 21 (4) (2019)
Jichun Yang, Shuqing Yu, Zhirong Yang, Yusong Yan, Yao Chen, Hongmei Zeng, Fei Ma, Yanxia Shi, Yehui Shi, Zilu Zhang, Feng Sun
Efficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (4) (2019)
Chengyi Ding, Zhirong Yang, Shengfeng Wang, Feng Sun, Siyan Zhan
The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study. Endocrine 60 (2) (2018)
Jun Yang, Chao Huang, Shanshan Wu, Yang Xu, Ting Cai, Sanbao Chai, Zhirong Yang, Feng Sun, Siyan Zhan
The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials. PloS one 12 (12) (2017)

Feng Sun.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Feng Sun